Danco Laboratories agreed to pay $765,000 April 12 to settle accusations of the drug distributor importing active pharmaceutical ingredients for its one drug, Mifeprex (mifepristone), and not marking its country of origin or paying marking duties.
Read the full post on Becker's Hospital Review - Healthcare News
